BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients: Clinical presentation

被引:37
作者
Blickstein, D
Aviram, A
Luboshitz, J
Prokocimer, M
Stark, P
Bairey, O
Sulkes, J
Shaklai, M
机构
[1] RABIN MED CTR,DIV HEMATOL,IL-49100 PETAH TIQWA,ISRAEL
[2] RABIN MED CTR,EPIDEMIOL UNIT,IL-49100 PETAH TIQWA,ISRAEL
关键词
D O I
10.1182/blood.V90.7.2768.2768_2768_2771
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the diagnostic criteria of essential thrombocythemia (ET) is the absence of the Philadelphia chromosome (Ph-neg). On the molecular level, Ph-neg ET patients may carry BCR-ABL transcript, The natural history of BCR-ABL positive Ph-neg ET patients is undetermined. We examined the BCR-ABL status by reverse transcriptase two-step nested polymerase chain reaction in bone marrow aspirates of 25 Ph-neg ET patients. We found 12 BCR-ABL positive and 13 BCR-ABL negative patients in the study group. The comparison showed that the two groups had similar clinical and laboratory characteristics, except for a significant increased patients' age and decreased polymorphonuclear cell count in the BCR-ABL positive group, During a median follow-up of 20 and 22.5 months for the BCR-ABL negative and positive groups, respectively, there was neither blastic transformation nor unrelated death in both groups, We conclude that it is important to look for BCR-ABL transcript in Ph-neg ET patients and to follow them closely to investigate the nature of this translocation in this group of patients, (C) 1997 by The American Society of Hematology.
引用
收藏
页码:2768 / 2771
页数:4
相关论文
共 26 条
[1]  
Athens John W., 1993, P1969
[2]  
BEDI A, 1994, BLOOD, V83, P2038
[3]  
BELLUCCI S, 1986, CANCER, V58, P2440, DOI 10.1002/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO
[4]  
2-Y
[5]   THE CHRONIC MYELOGENOUS LEUKEMIA SPECIFIC P210-PROTEIN IS THE PRODUCT OF THE BCR/ABL HYBRID GENE [J].
BEN-NERIAH, Y ;
DALEY, GQ ;
MESMASSON, AM ;
WITTE, ON ;
BALTIMORE, D .
SCIENCE, 1986, 233 (4760) :212-214
[6]  
BIERNAUX C, 1995, BLOOD, V86, P3118
[7]  
CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
[8]   GENETIC MECHANISMS IN TUMOR INITIATION AND PROGRESSION .7. ONCOGENE ACTIVATION BY CHROMOSOMAL REARRANGEMENT IN CHRONIC MYELOCYTIC-LEUKEMIA [J].
DEKLEIN, A .
MUTATION RESEARCH, 1987, 186 (02) :161-172
[9]  
FIALKOW PJ, 1981, BLOOD, V58, P916
[10]   PHILADELPHIA CHROMOSOMAL BREAKPOINTS ARE CLUSTERED WITHIN A LIMITED REGION, BCR, ON CHROMOSOME-22 [J].
GROFFEN, J ;
STEPHENSON, JR ;
HEISTERKAMP, N ;
DEKLEIN, A ;
BARTRAM, CR ;
GROSVELD, G .
CELL, 1984, 36 (01) :93-99